Arbutus to Report Second Quarter 2023 Financial Results and Provide Corporate Update

WARMINSTER, Pa., July 20, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target...

Related Keywords

Lisam Caperelli , ,Arbutus Biopharma Corporation Nasdaq ,Biopharma Corporation ,Markets ,